We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




New Biology Lab Tools Speed Up Tumor Dissection

By LabMedica International staff writers
Posted on 12 Sep 2024
Print article
Image: Scanning microscopy images of the microDicer and microGrate (Photo courtesy of Seth Cordts and Saisneha Koppaka)
Image: Scanning microscopy images of the microDicer and microGrate (Photo courtesy of Seth Cordts and Saisneha Koppaka)

As intriguing as working in a modern biology lab can be, much of the time, it involves repetitive, detailed tasks that need to be completed before the actual research begins. For instance, cancer researchers today can test multiple cancer therapies, including immunotherapies, on hundreds or even thousands of small, lab-grown tumor samples called organoids. However, creating organoids often requires researchers to manually mince a fresh tumor into tiny pieces using scissors, cutting the specimen into submillimeter sizes. This tedious and time-consuming task is usually carried out by highly skilled – and often overqualified – graduate students or research scientists. Fortunately, those days may be coming to an end as researchers have developed two innovative tools to streamline the precision cutting of tumor samples into submillimeter-scale organoids.

Much like kitchen gadgets used to dice vegetables or grate cheese, the microDicer (µDicer) and microGrater (µGrater), developed by scientists at the Stanford School of Engineering (Stanford, CA, USA), promise to improve both the consistency and quality of samples. This is crucial, as it directly influences the accuracy of downstream experiments, such as drug response testing. In cancer immunotherapy research, preserving the spatial relationships between tumor cells and infiltrating immune cells is key to accurately testing therapies. These new tools allow researchers to more efficiently create organoids that retain these vital cellular relationships. As detailed in the journal Microsystems & Nanoengineering, which features the study on the microDicer and microGrater, the microDicer’s blades are made using micromachining techniques from the semiconductor industry. The silicon blades are etched into a reactive plasma, forming a honeycomb-like mesh with sharp edges. Researchers use the microDicer by shaving thin tissue layers and pressing them through this honeycomb mesh, creating precise, uniform tumor samples.

In contrast, the microGrater features an array of blades shaped like rounded rectangles, each slightly longer than half a millimeter. The beveled edges of these rectangles act as blades, shaving off precise organoids as the tissue is moved across the grater. The tumors being studied are grown in lab mice, serving as a reliable model for human tumors. Ultimately, the aim is to develop personalized cancer therapies by collecting samples from individual patients and testing which immunotherapies will be most effective for them. These new tools standardize the organoid preparation process in ways manual cutting cannot, potentially speeding up regulatory approvals, such as from the FDA, for broader clinical applications.

“These new tools will speed up the manual lab work, but their utility goes beyond that obvious advantage,” said Sindy Tang, an associate professor of mechanical engineering and senior author of the study. “These tools produce uniform-sized organoids and the blades can be varied to whatever size the researcher requires.”

Related Links:
Stanford University
Stanford Medicine

New
Gold Member
ANCA IFA
Kallestad Autoimmune ANCA IFA Complete Kit
Unit-Dose Packaging solution
HLX
New
Four-in-One Desktop Testing Solution
GULP-1sim/GULP-1ble
New
Hemacytometer Cover Glasses
Propper Hemacytometer Cover Glasses

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Molecular Diagnostics

view channel
Image: The CELLSEARCH System is the first and only clinically validated, FDA-cleared system for identification, isolation, and enumeration of CTCs from a simple blood test (Photo courtesy of Menarini, Inc.)

Early Blood Test Predicts Survival in Patients with Metastatic Prostate Cancer

Before prostate cancer spreads, it can be effectively treated with surgery or radiation. However, once the cancer metastasizes and becomes incurable, systemic treatments are used to extend survival as... Read more

Hematology

view channel
Image: The discovery of a new blood group has solved a 50- year-old mystery (Photo courtesy of 123RF)

Newly Discovered Blood Group System to Help Identify and Treat Rare Patients

The AnWj blood group antigen, a surface marker discovered in 1972, has remained a mystery regarding its genetic origin—until now. The most common cause of being AnWj-negative is linked to hematological... Read more

Microbiology

view channel
Image: The Accelerate Arc System has been granted US FDA 510(k) clearance (Photo courtesy of Accelerate Diagnostics)

Automated Positive Blood Culture Sample Preparation Platform Designed to Fight Against Sepsis and AMR

Delayed administration of antibiotics to patients with bloodstream infections significantly increases the risk of morbidity and mortality. For optimal therapeutic outcomes, it is crucial to rapidly identify... Read more

Industry

view channel
Image: The GeneXpert system’s fast PCR Xpert tests can fight AMR and superbugs with fast and accurate PCR in one hour (Photo courtesy of Cepheid)

Cepheid Partners with Fleming Initiative to Fight Antimicrobial Resistance

Antimicrobial resistance (AMR) is responsible for over one million deaths globally each year and poses a growing challenge in treating major infectious diseases like tuberculosis, Escherichia coli (E.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.